Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
Smith+Nephew announced the European commercial launch of its CARTIHEAL AGILI-C Cartilage Repair Implant, following its 2024 US introduction. Clinical data show superior KOOS outcomes versus standard of care (microfracture/debridement) out to 60 months, published in the American Journal of Sports Medicine.
Key figures
- Employees
- 17000
- Annual sales 2025
- $6.2 billion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.